Drägerwerk AG & Co. KGaA (FRA:DRW8)

Germany flag Germany · Delayed Price · Currency is EUR
50.20
-1.80 (-3.46%)
Last updated: Apr 11, 2025
10.33%
Market Cap 1.02B
Revenue (ttm) 3.37B
Net Income (ttm) 124.41M
Shares Out n/a
EPS (ttm) 6.63
PE Ratio 8.24
Forward PE n/a
Dividend 1.97 (4.12%)
Ex-Dividend Date May 12, 2025
Volume n/a
Average Volume 69
Open 50.20
Previous Close 52.00
Day's Range 50.20 - 50.20
52-Week Range 39.10 - 55.80
Beta n/a
RSI 50.15
Earnings Date Apr 2, 2025

About Drägerwerk AG & Co. KGaA

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departmen... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 1889
Employees 16,585
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol DRW8
Full Company Profile

Financial Performance

In 2024, Drägerwerk AG & Co. KGaA's revenue was 3.37 billion, a decrease of -0.08% compared to the previous year's 3.37 billion. Earnings were 124.41 million, an increase of 12.65%.

Financial Statements

News

EQS-AGM: Drägerwerk AG & Co. KGaA: Announcement of the Convening of the General Meeting in Lübeck on 09.05.2025 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution

EQS-News: Drägerwerk AG & Co. KGaA / Announcement of the Convening of the General Meeting Drägerwerk AG & Co. KGaA: Announcement of the Convening of the General Meeting in Lübeck on 09.05.2025 accordi...

9 days ago - Wallstreet:Online

Drägerwerk AG & Co KGaA (DGWPF) Full Year 2024 Earnings Call Transcript

Drägerwerk AG & Co KGaA (OTCPK:DGWPF) Full Year 2024 Earnings Conference Call March 31, 2025 9:00 AM ET Company Participants Stefan Dräger – Chief Executive Officer Gert-Hartwig Lescow – Chief Financi...

11 days ago - Seeking Alpha

Drägerwerk: 2024 Profit Surge & Dividend Boost!

Drägerwerk AG & Co. KGaA shines with robust financial growth in 2024, boosting dividends and setting ambitious targets for the future. Jetzt den vollständigen Artikel lesen

11 days ago - Wallstreet:Online

EQS-News: Drägerwerk AG & Co. KGaA: Dräger increases net profit in fiscal year 2024 and raises dividend

EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Annual Report/Dividend Drägerwerk AG & Co. KGaA: Dräger increases net profit in fiscal year 2024 and raises dividend 31.03.2025 / 07:30 CET/CEST The i...

11 days ago - Wallstreet:Online

EQS-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014: Purchase of own shares – final notice

EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Miscellaneous Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014: Purchase of own shares – final...

2 months ago - Wallstreet:Online

EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures 2024: Net sales just below and earnings just above expectations – Forecast 2025

EQS-Ad-hoc: Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results/Forecast Drägerwerk AG & Co. KGaA: Preliminary figures 2024: Net sales just below and earnings just above expectations – Forecas...

3 months ago - Wallstreet:Online

EQS-News: Drägerwerk AG & Co. KGaA: Changes in the chair of the Dräger Supervisory Board

EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Personnel Drägerwerk AG & Co. KGaA: Changes in the chair of the Dräger Supervisory Board 11.12.2024 / 14:06 CET/CEST The issuer is solely responsible ...

4 months ago - Wallstreet:Online